Madrigal Pharmaceuticals inc. buy melinda
Start price
23.10.17
/
50%
€40.66
Target price
01.11.17
€49.61
Performance (%)
10.91%
End price
01.11.17
€45.10
Summary
This prediction ended on 01.11.17 with a price of €45.10. The BUY prediction by melinda finished with a performance of 10.91%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Madrigal Pharmaceuticals inc. | 2.640% | 2.640% | 21.229% | 209.240% |
iShares Core DAX® | 0.410% | -2.543% | 14.415% | 14.709% |
iShares Nasdaq 100 | -2.154% | 4.721% | 33.222% | 52.436% |
iShares Nikkei 225® | -0.066% | -0.307% | 8.496% | 3.743% |
iShares S&P 500 | -0.527% | 3.848% | 28.621% | 47.348% |
Comments by melinda for this prediction
In the thread Madrigal Pharmaceuticals inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
Madrigal Pharmaceuticals präsentiert präklinische das therapeutische Potential der Agonist rezeptorselektiven β-selektive Thyroidhormon, SW-3196, bei dem Treffen der Leber AASLD unterstützen
Die Ergebnisse zeigen , dass MGL-3196 metabolische Vorteile bieten, entzündungshemmende und anti-fibrotische in einer langfristigen Ernährung reich an Fett, NASH Mäuse
(Vom Mitglied beendet)
Stopped prediction by melinda for Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€96.54
23.11.20
23.11.20
€108.00
23.11.21
23.11.21
-25.42%
24.11.21
24.11.21
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€124.73
26.02.18
26.02.18
€135.30
31.05.18
31.05.18
56.77%
31.05.18
31.05.18
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€73.53
06.12.17
06.12.17
€90.20
29.12.17
29.12.17
14.44%
29.12.17
29.12.17
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€170.38
26.09.13
26.09.13
€210.00
26.03.14
26.03.14
-34.33%
26.03.14
26.03.14
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€156.52
06.06.12
06.06.12
€175.00
06.12.12
06.12.12
27.93%
06.12.12
06.12.12